Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Organovo Holdings Inc
ONVOCurrent price
1.72 USD
+0.07 USD (+4.24%)
Last closed
1.96 USD
Company
www.organovo.com
ISIN
US68620A2033
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
3 096 000 USD
Yield for 12 month
-86.08 %
1Y
3Y
5Y
10Y
15Y
ONVO
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company's lead candidate is FXR314, which is phase 2/3clinical trial for indication of inflammatory bowel disease with a clinical focus on ulcerative colitis; and completed phase 1 clinical trial for the indication of liver fibrosis with a clinical focus steatohepatitis. Organovo Holdings, Inc. has research collaborations with Yale School of Medicine, Knight Cancer Institute at Oregon Health & Science University, and the University of Virginia for research of NovoGen Bioprinters. The company was incorporated in 2007 and is headquartered in San Diego, California. Address: 11555 Sorrento Valley Road, San Diego, CA, United States, 92121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
64.80 USDP/E ratio
–Dividend Yield
–Current Year
+109 000 USD
Last Year
+370 000 USD
Current Quarter
+24 000 USD
Last Quarter
+30 000 USD
Current Year
+109 000 USD
Last Year
+77 000 USD
Current Quarter
+22 000 USD
Last Quarter
+29 000 USD
Key Figures ONVO
1 year
3 years
5 years
10 years
EBITDA
-12 282 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-123.36 %
PEG Ratio
–
Return On Equity TTM
-378.40 %
Wall Street Target Price
64.80 USD
Revenue TTM
122 000 USD
Book Value
0.26 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
380.00 %
Dividend Yield
–
Gross Profit TTM
-5 112 000 USD
Earnings per share
-10.08 USD
Diluted Eps TTM
-10.08 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ONVO
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History ONVO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:12
Payout Ratio
–
Last Split Date
21.03.2025
Stock Valuation ONVO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
23.66
Price Sales TTM
25.38
Enterprise Value EBITDA
-0.34
Price Book MRQ
8.21
Financials ONVO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ONVO
For 52 weeks
1.56 USD
21.96 USD
50 Day MA
4.32 USD
Shares Short Prior Month
674 740
200 Day MA
5.43 USD
Short Ratio
0.54
Shares Short
73 382
Short Percent
4.14 %
BeatStart